Usefulness of inflammation and infection biomarkers in the Emergency Department;Utilidad de los biomarcadores de inflamación e infección en los servicios de urgencias

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue 3, 2014, Pages 177-190

  Julián Jiménez, Agustín ^a   Candel González, Francisco Javier ^b   González Del Castillo, Juan ^b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Bacteremia; Biomarkers; C reactive protein; Emergency department; Lactate; Pro adrenomedullin; Procalcitonin; Sepsis; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER;

BACTERIAL INFECTION; DISEASE MARKER; DISEASE SEVERITY; EMERGENCY CARE; EMERGENCY WARD; HUMAN; INFECTION; INFLAMMATION; INTENSIVE CARE; PATIENT CARE; PROGNOSIS; REVIEW; SEPSIS; SEPTIC SHOCK; ALGORITHM; EMERGENCY; EMERGENCY HEALTH SERVICE; METABOLISM; PRACTICE GUIDELINE; BACTEREMIA; DISEASE COURSE;

ALGORITHMS; BIOLOGICAL MARKERS; EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; HUMANS; INFECTION; INFLAMMATION; PRACTICE GUIDELINES AS TOPIC;

EID: 84896733780     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.01.005     Document Type: Review

References (181)

1. Grupo para el Estudio de la Infección en Urgencias Estudio epidemiológico de las infecciones en el Área de Urgencias Emergencias 12 2000 80 89
2. J. González-Castillo, F.J. Candel, and A. Julián- Jiménez Antibióticos y el factor tiempo en la infección en urgencias Enferm Infecc Microbiol Clin 2012 10.1016/j.eimc.2012.01.025
3. J.M. Pines Timing of antibiotics for acute, severe infections Emerg Med Clin North Am 26 2008 245 257
4. A. Kumar, D. Roberts, K.E. Wood, B. Light, J.E. Parrillo, and S. Sharma et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589 1596
5. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
6. C. León, L. García-Castrillo, M. Moya, A. Artigas, M. Borges, and F.J. Candel et al. Documento de consenso (SEMES-SEMICYUC). Recomendaciones del manejo diagnóstico-terapéutico inicial y multidisciplinario de la sepsis grave en los Servicios de Urgencias Hospitalarios Med Intensiva 31 2007 375 387
7. D.A. Talan, G.J. Moran, and F.M. Abrahamian Severe sepsis and septic shock in the emergency department Infect Dis Clin North Am 22 2008 1 31
8. A. Esteban, F. Frutos-Vivar, N.D. Ferguson, O. Peñuelas, J.A. Lorente, and F. Gordo et al. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward Crit Care Med 35 2007 1284 1289
9. R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinguer, A.M. Fein, and W.A. Knaus et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee Chest 101 1992 1644 1655
10. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Intensive Care Med 29 2003 530 538
11. A. Julián-Jiménez, M.J. Palomo, N. Laín, and J. Estebaran Nuevas alternativas terapéuticas para la sepsis grave, pero sin olvidar los viejos retos: detección y manejo precoz de los pacientes Med Intensiva 35 2011 588 590
12. J.M. De Miguel-Yanes, J.A. Andueza-Lillo, V.J. González-Ramallo, L. Pastor, and J. Muñoz Failure to implement evidence-based clinical guidelines for sepsis at the ED Am J Emerg Med 24 2006 553 559
13. X. Jiménez Fábrega, J.L. Espila Etxeberria, and J. Gallardo Meno Códigos de activación: pasado, presente y futuro en España Emergencias 23 2011 311 318
14. F.J. Candel, F. Martínez-Sagasti, M. Matesanz, J. González de Castillo, F. Ortuño, and F.J. Martín et al. Detección y manejo inicial del síndrome de respuesta inflamatoria sistémica en las urgencias de medicina. Análisis de 24 horas en un hospital general An Med Interna (Madrid) 25 2008 205 208
15. a ed. 2012 Grupo SANED Madrid 21 26
16. A. Beceiro, M. Tomás, and G. Bou Resistencia a los antimicrobianos y virulencia, ¿una asociación beneficiosa para el mundo microbiano? Enferm Infecc Microbiol Clin 30 2012 492 499
17. A. Julián-Jiménez Biomarcadores de infección en urgencias: ¿cuáles pueden sernos útiles? Emergencias 24 2012 343 345
18. P. Tudela, C. Prat, A. Lacoma, and J.M. Mòdol Biomarcadores y sospecha de infección en los servicios de urgencias Med Clin (Barc) 139 2012 33 37
19. A. Lacoma, C. Prat, and V. Ausina Relevancia de los marcadores de inflamación en el diagnóstico, pronóstico y nuevas formas de tratamiento de las enfermedades infecciosas Enferm Infecc Microbiol Clin 28 2010 263 265
20. C. Pierrakos, and J.L. Vincent Sepsis biomarkers: a review Critical Care 14 2010 R15
21. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
22. D.A. Morrow, and J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
23. K. Letham, and A. Gray El objetivo de las 4 horas (4-hour target) en los servicios de urgencias del National Health Service: un comentario crítico Emergencias 24 2012 69 72
24. US National Library of Medicine. National Institutes of Health. PubMed [consultado 18 Ago 2012]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed
25. C. Mitaka Clinical laboratory differentiation on infectious versus non-infectious systemic inflammatory response syndrome Clin Chim Acta 351 2005 17 29
26. I. Herzum, and H. Renz Inflammatory markers in SIRS, sepsis and septic shock Curr Med Chem 15 2008 581 587
27. L. Martí, A. Moreno, X. Filella, J.L. Marín, M. Almela, and N. Benito et al. Valor de las citosinas proinflamatorias como factor de predicción de sepsis y mortalidad en el anciano con fiebre Med Clin (Barc) 121 2003 361 366
28. A. Julián, R. Salcedo, and S. Moreno Síndromes de sepsis M.S. Moya Mir, P. Piñera Salmerón, M. Mariné Blanco, Tratado de Medicina de Urgencias 2011 Ergon Madrid 985 1000
29. E.A. Panacek, J.C. Marshall, T.E. Albertson, D.H. Johnson, S. Johnson, and R.D. MacArthur et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels Crit Care Med 32 2004 2173 2182
30. R.T. Patel, K.I. Deen, D. Youngs, J. Warwick, and M.R. Keighley Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis Br J Surg 81 1994 1306 1308
31. C. Prat, J.M. Sancho, J. Domínguez, B. Xicoy, M. Giménez, and C. Ferra et al. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia Leuk Lymphoma 49 2008 1752 1761
32. S.M. El Maghraby, M.M. Moneer, M.M. Ismail, L.M. Shalaby, and H.A. El Mahallawy The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies J Pediatr Hematol Oncol 29 2007 131 136
33. S. Fujishima, J. Sasaki, Y. Shinozawa, K. Takuma, H. Kimura, and M. Suzuki et al. Serum MIP-1 alpha and IL-8 in septic patients Intensive Care Med 22 1996 1169 1175
34. Y. Heper, E.H. Akalin, R. Mistik, S. Akgoz, O. Tore, and G. Goral et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock Eur J Clin Microbiol Infect Dis 25 2006 481 491
35. C.H. Wang, M.J. Gee, C. Yang, and Y.C. Su A new model for outcome prediction in intra-abdominal sepsis by the linear discriminant function analysis of IL-6 and IL-10 at different heart rates J Surg Res 132 2006 46 51
36. A. Marchant, M.L. Alegre, A. Hakim, G. Pierard, G. Marecaux, and G. Friedman et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock J Clin Immunol 15 1995 266 273
37. K. Kofoed, O. Andersen, G. Kronborg, M. Tvede, J. Petersen, and J. Eugen-Olsen et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study Crit Care 11 2007 R38
38. I.A. Meynarr, W. Droog, M. Batstra, R. Vreede, and P. Herbrink In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, IL-6, or LBP Crit Care Res Pract 2011 2011 594645
39. C. Chiesa, G. Pellegrini, A. Panero, J.F. Osborn, F. Signore, and M. Assumma et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection Clin Chem 49 2003 60 68
40. X. Schmit, and J.L. Vincent The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis Infection 36 2008 213 219
41. R.C. Couto, J.A. Barbosa, T.M. Pedrosa, and F.M. Biscione C-reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis: an intervention study Braz J Infect Dis 11 2007 240 245
42. G. Seller-Perez, M.E. Herrera-Gutiérrez, M. Lebrón- Gallardo, I. Toro-Peinado, L. Martin-Hita, and J.A. Porras-Ballesteros Valor de la determinación de la proteína C reactiva como marcador pronóstico y de infección en pacientes críticos Med Clin (Barc) 125 2005 761 765
43. P. Tudela, C. Prat, A. Lacoma, J.M. Mòdol, J. Domínguez, and M. Giménez et al. Biomarcadores para la predicción en urgencias de infección bacteriana, bacteriemia y gravedad Emergencias 24 2012 348 356
44. L. Simon, F. Gauvin, D.K. Amre, P. Saint-Louis, and J. Lacroix Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Clin Infect Dis 39 2004 206 217
45. L. Simon, F. Gauvin, D.K. Amre, P. Saint-Louis, and J. Lacroix Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Clin Infect Dis 39 2004 206 217 Erratum in: Clin Infect Dis. 2005;40:1386-8
46. A. Julián, M.J. Palomo, R. Ortiz, A. Pedrosa, R. Parejo, and R. Salcedo Utilidad de la procalcitonina y la proteína C reactiva en el paciente con sepsis en urgencias Emergencias 21 2009 23 27
47. K. Reinhart, M. Meisner, and F.M. Brunkhorts Markers for sepsis diagnosis: what is useful? Crit Care Clin 22 2006 503 519
48. D.H. Wyllie, I.C. Bowler, and T.E. Peto Bacteremia prediction in emergency medical admissions: role of C reactive protein J Clin Pathol 58 2005 352 356
49. P. Chalupa, O. Beran, H. Herwald, N. Kasprikova, and M. Holub Evaluation of potential biomarkers for the discrimination of bacterial and viral infections Infection 39 2011 411 417
50. B. Suberviola, A. Castellanos-Ortega, A. González-Castro, L.A. García-Astudillo, and B. Fernández-Miret Valor pronóstico del aclaramiento de procalcitonina, PCR y leucocitos en el shock séptico Med Intensiva 36 2012 177 184
51. M. Christ-Crain, and B. Müller Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 135 2005 451 460
52. M. Plebani, and G. Lippi Biological variation and reference change values: an essential piece of the puzzle of laboratory testing Clin Chem Lab Med 50 2012 189 190
53. C.G. Fraser, G. Lippi, and M. Plebani Reference change values Clin Chem Lab Med 50 2012 963 964
54. A. Barassi, F. Pallotti, and G.V. Melzi Biological variation of procalcitonin in healthy individuals Clin Chem 50 2004 1878
55. D. Pineda, L. Rodelgo, A. Cabezas, R. Ramos, D. Lamuño, and A. Julián-Jiménez et al. Significación clínica de la concentración de procalcitonina durante la monitorización de la sepsis. Estimación de la variabilidad biológica y del valor de referencia del cambio Rev Lab Clin 5 Supl C 2012 380
56. K.L. Becker, R. Snider, and E.S. Nylen Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations Crit Care Med 36 2008 941 952
57. M.D. De Kruif, M. Limper, H. Gerritsen, C.A. Spek, D.P. Brandjes, and H. ten Cate et al. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department Crit Care Med 38 2010 457 463
58. P. Hausfater, G. Juillien, B. Madonna-Py, J. Haroche, M. Bernard, and B. Riou Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department Crit Care 11 2007 R60
59. P. Indino, P. Lemarchand, P. Bady, A. de Torrente, L. Genne, and D. Genne Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis Int J Infect Dis 12 2008 319 324
60. S. Harbarth, K. Holeckova, C. Froidevaux, D. Pittet, B. Ricou, and G.E. Grau et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically Ill patients admitted with suspected sepsis Am J Respir Crit Care Med 164 2001 396 402
61. P. Hausfater, S. Garric, S. Ben Ayed, M. Rosenheim, M. Bernard, and B. Riou Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study Clin Infect Dis 34 2002 895 901
62. J.U. Jensen, L. Heslet, T.H. Jensen, K. Espersen, P. Steffensen, and M. Tvede Procalcitonin increase in early identification of critically ill patients at high risk of mortality Crit Care Med 34 2006 2596 2602
63. A. Viallon, S. Guyomarc'h, O. Marjollet, C. Berger, A. Carricajo, and F. Robert et al. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin Eur J Emerg Med 15 2008 26 33
64. M. Limper, M.D. de Kruif, A.J. Duits, D.P. Brandjes, and E.C. van Gorp The diagnostic role of procalcitonin and others biomarkers in discriminating infectious from non-infectious fever J Infect 60 2010 409 416
65. S. Riedel Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis Diagn Microbiol Infect Dis 73 2012 221 227
66. B. Tang, G.D. Eslick, J.C. Craig, and A.S. McLean Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis Lancet Infect Dis 7 2007 210 217
67. C.C. Lee, S.Y. Chen, C.L. Tsai, S.C. Wu, W.C. Chiang, and J.L. Wang et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department Shock 29 2008 322 327
68. N.I. Shapiro, S. Trzeciak, J.E. Hollander, R. Birkhahn, R. Otero, and T.M. Osborn et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis Crit Care Med 37 2009 96 104
69. P. Schuetz, M. Christ-Crain, and B. Muller Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly 139 2009 318 326
70. H. Tang, T. Huang, J. Jing, H. Shen, and W. Cui Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis Infection 37 2009 497 507
71. P. Schuetz, W. Albrich, and B. Mueller Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future BMC Medicine 9 2011 107
72. S. Kibe, K. Adams, and G. Barlow Diagnostic and prognostic biomarkers of sepsis in critical care J Antimicrob Chemother 66 Suppl 2 2011 ii33 ii40
73. M. Christ-Crain, and S.M. Opal Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia Crit Care 14 2010 203
74. V. Nobre, S. Harbarth, J.D. Graf, P. Rohner, and J. Pugin Use of procalcitonin to shorten antibiotic treatment duration in septic patients Am J Respir Crit Care Med 177 2008 498 505
75. P.E. Charles, C. Tinel, S. Narbar, S. Aho, S. Prin, and J.M. Doise et al. Procalcitonin kinetics within the first days of sepsis; relationship with the appropriateness of antibiotic therapy and outcome Crit Care 13 2009 R38
76. L. Bouadma, C.E. Luyt, F. Tubach, C. Cracco, A. Álvarez, and C. Schwebel et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial Lancet 375 2010 463 474
77. M. Christ-Crain, and B. Müller Biomarkers in respiratory tract infections: diagnosis guides to antibiotic prescription, prognostic markers and mediators Eur Respir J 30 2007 556 573
78. M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser, M.M. Gencay, P.R. Huber, and M. Tamm et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised single-blinded intervention trial Lancet 363 2004 600 607
79. M. Christ-Crain, D. Stolz, R. Bingisser, C. Müller, D. Miedinger, and P. Huber et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia Am J Respir Crit Care Med 174 2006 84 93
80. D. Stolz, M. Christ-Crain, R. Binguisser, J. Leuppi, D. Miedinger, and C. Müller et al. Antibiotic treatment of exacerbations of COPD. A randomized, controlled trial comparing procalcitonin-guidance with standard therapy Chest 131 2007 9 19
81. J.L. Kook, S.R. Chao, L. Jennifer, and P.A. Robinson Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital Infect Control Hosp Epidemiol 33 2012 424 426
82. J.S. Oh, S. Kim, Y.M. Oh, S.M. Choe, G.H. Choe, and S.P. Choe et al. The usefulness of semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration Am J Emerg Med 27 2009 859 863
83. A. Julián-Jiménez, M.J. Palomo, J.G. Sentenac, and J. Aguilar Utilidad de la procalcitonina y la proteína C reactiva en la neumonía adquirida en la comunidad en urgencias Enferm Infecc Microbiol Clin 28 2010 666 667
84. A. Julián Jiménez ¿Cuándo y dónde ingresar las neumonías adquiridas en la comunidad? Emergencias 23 2011 161 163
85. C. Chirouze, H. Schuhmacher, C. Rabaud, H. Gil, N. Khayat, and J.M. Estavoyer et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever Clin Infect Dis 35 2002 156 161
86. P. Tudela, A. Lacoma, C. Prat, J. Mòdol, M. Giménez, and J. Barallat et al. Predicción de bacteriemia en los pacientes con sospecha de infección en urgencias Med Clin (Barc) 135 2010 685 690
87. A. Julián-Jiménez, E.J. Laserna-Mendieta, J. Timón-Zapata, and A. Cabezas-Martínez Importancia de la sospecha clínica y confirmación de bacteriemia en los servicios de urgencias Med Clin (Barc) 137 2011 426 427
88. M.H. Kim, G. Lim, S.Y. Kang, W.I. Lee, J.T. Suh, and H.J. Lee Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever Yonsei Med J 52 2011 276 281
89. S. Riedel, J.H. Meléndez, A.T. An, J.E. Rosenbaum, and J.M. Zenilman Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department Am J Clin Pathol 135 2011 182 189
90. C.P. Su, T.H. Chen, S.Y. Chen, W.C. Ghiang, G.H. Wu, and H.Y. Sun et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: A preliminary report J Microbiol Immunol Infect 44 2011 449 455
91. R.P. Peters, J.W. Twisk, M.A. van Agtmael, and A.B. Groeneveld The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patiens Clin Microbiol Infect 12 2006 1207 1213
92. A. Julián-Jiménez, J. Timón-Zapata, E.J. Laserna-Mendieta, and A. Cabezas-Martínez Utilidad de los hemocultivos en urgencias Rev Clin Esp 211 2011 609 610
93. A.E. Jones, J.F. Fiechtl, M.D. Brown, J.J. Ballew, and J.A. Kline Procalcitonin test in the diagnosis of bacteremia: a meta-analysis Ann Emerg Med 50 2007 34 41
94. M. Meisner, J. Schmidt, H. Hüttner, and K. Tschaikowsky The natural elimination rate of procalcitonin in patients with normal and impaired renal function Intensive Care Med 26 2000 S212 S216
95. A.A. Dahaba, B. Hagara, A. Fall, P.H. Rehak, W.F. List, and H. Metzler Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis Br J Anaesth 97 2006 503 508
96. C.H. Li, R.B. Yang, J.H.S. Pang, S.S. Chang, C.C. Lin, and C.H. Chen et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department Acad Emerg Med 18 2011 122 126
97. E. Aznar-Oroval, M. Sánchez-Yepes, P. Lorente-Alegre, M.C. San Juán-Gadea, B. Ortiz-Muñoz, and P. Pérez-Ballestero et al. Valor diagnóstico de la procalcitonina, la interleucina 8, la interleucina 6 y la proteína C reactiva en la detección de bacteriemia y fungemia en pacientes con cáncer Enferm Infecc Microbiol Clin 28 2010 273 277
98. S. Schüttrumpf, L. Binder, T. Hagemann, D. Berkovic, L. Trümper, and C. Binder Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations Clin Infect Dis 43 2006 468 473
99. C. Ferrá, A. Lacoma, O. García, P. Marcos, J. Domínguez, and J.M. Ribera Relación entre los valores séricos de procalcitonina y las complicaciones y supervivencia de pacientes con hemopatías malignas ingresados en una unidad de vigilancia intensiva Med Clin (Barc) 138 2012 385 388
100. J.M. Caterino, M.D. Scheatzle, M.L. Forbes, and J.A. D'Antonio Bacteremic elder emergency department patients: Procalcitonin and white count Acad Emerg Med 11 2004 393 396
101. F. Stuker, F. Herrmann, J.D. Graf, J.P. Michel, K.H. Krause, and G. Gavazzi Procalcitonin and infection in elderly patients J Am Geriatr Soc 53 2005 1392 1395
102. C.C. Lai, S.Y. Chen, C.Y. Wang, J.Y. Wang, C.P. Su, and C.H. Liao et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department J Am Geriatr Soc 58 2010 518 522
103. L. Marti, C. Cervera, X. Filalla, J.L. Marin, M. Almela, and J.M. Gatell et al. Respuesta inflamatoria en pacientes ancianos con bacteriemia Enferm Infecc Microbiol Clin 26 2008 146 149
104. K. Tamaki, Y. Kogata, D. Sugiyama, T. Nakazawa, S. Hatachi, and G. Kageyama et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases J Rheumatol 35 2008 114 119
105. L. Silva, C. Barbadillo, M. Fernández, and T. Otón Los otros biomarcadores. ¿Qué debe saber el reumatólogo? Semin Fund Esp Reumatol 12 2011 67 72
106. M. Piechota, M. Banach, R. Irzmanski, M. Barylski, M. Piechota-Urbanska, and J. Kowalski et al. Plasma endothelin-1 levels in septic patients J Intensive Care Med 22 2007 232 239
107. P. Schuetz, D. Stolz, B. Mueller, N.G. Morgenthaler, J. Struck, and C. Mueller et al. Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia BMC Infect Dis 8 2008 22
108. S. Gibot, M.N. Kolopp-Sarda, M.C. Bene, A. Cravoisy, B. Levy, and G.C. Faure et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis Ann Intern Med 141 2004 9 15
109. S. Gibot, A. Cravoisy, M.N. Kolopp-Sarda, M.C. Bene, G. Faure, and P.E. Bollaert et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis Crit Care Med 33 2005 792 796
110. J. Latour-Pérez, A. Alcalá-López, M.A. García-García, J.F. Sánchez-Hernández, C. Abad-Terrado, and J.A. Viedma-Conteras et al. Valor pronóstico de los niveles plasmáticos de sTREM-1 en pacientes con sepsis: un estudio de cohortes Med Intensiva 34 2010 231 236
111. J. Latour-Pérez, A. Alcalá-López, M.A. García-García, J.F. Sánchez-Hernández, C. Abad-Terrado, and J.A. Viedma-Conteras et al. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome Clin Biochem 43 2010 720 724
112. H. Aalto, A. Takala, H. Kautiainen, S. Siitonen, and H. Repo Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection Scand J Infect Dis 39 2007 596 603
113. P. Cardelli, M. Ferraironi, R. Amodeo, F. Tabacco, R.A. De Blasi, and M. Nicoletti et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis Int J Immunopathol Pharmacol 21 2008 43 49
114. J. Hoffmann Neutrophil CD64: a diagnostic marker for infection and sepsis Clin Chem Lab Med 47 2009 903 916
115. C.M. Marco-Schulke, M. Sánchez-Casado, V.A. Hortigüela- Martín, M. Quintana-Díaz, S. Rodríguez-Villar, and M.J. Pérez-Pedrero et al. Trombocitopenia grave al ingreso en una unidad de cuidados intensivos en pacientes con disfunción multiorgánica Med Intensiva 36 2012 185 192
116. G.T. Kinasewitz, S.B. Yan, B. Basson, P. Comp, J.A. Russell, and A. Cariou et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism Crit Care 8 2004 R82 R90
117. A.N. Zakariah, S.M. Cozzi, M. van Nuffelen, C.M. Clausi, O. Pradier, and J.L. Vincent Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients Crit Care Med 36 2008 1507 1512
118. C.P. Schneider, M.K. Angele, and W.H. Hartl Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery Crit Care 14 2010 R104
119. V. Pettila, J. Pentti, M. Pettila, O. Takkunen, and I. Jousela Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis Crit Care Med 30 2002 271 275
120. J.G. Heuer, G.R. Sharma, B. Gerlitz, T. Zhang, D.L. Bailey, and C. Ding et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis Crit Care Med 32 2004 1570 1578
121. A. Scherpereel, F. Depontieu, B. Grigoriu, B. Cavestri, A. Tsicopoulos, and T. Gentina et al. Endocan, a new endothelial marker in human sepsis Crit Care Med 34 2006 532 537
122. M. Ip, T.H. Rainer, N. Lee, C. Chan, S.S. Chau, and W. Leung et al. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections Diagn Microbiol Infect Dis 59 2007 131 136
123. C. Prat, J. Domínguez, F. Andreo, S. Blanco, A. Pallares, and F. Cuchillo et al. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia J Infect 52 2006 169 177
124. W. Jiang, H.F. Jiang, D.Y. Cai, C.S. Pan, Y.F. Qi, and Y.Z. Pang et al. Relationship between contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of rats in septic shock Regul Pept 118 2004 199 208
125. M. Christ-Crain, N.G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann, and B. Muller Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study Crit Care 9 2005 R816 R824
126. S. Krüger, S. Ewig, S. Giersdorf, O. Hartmann, N. Suttorp, T. Welte and the German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group Cardiovascular and inflammatory biomarkers to predict short and long-term survival in community-acquired pneumonia. Results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 2010 1426 1434
127. P. Herrero, D. Fernández, J.J. Gil, B. Prieto, J. Vázquez, and D. Miguel et al. Estudio piloto de la utilidad de la región medial de la proadrenomedulina (RM-proADM) en la valoración de la disnea de origen respiratorio en urgencias Emergencias 24 2012 357 365
128. D.T. Huang, D.C. Angus, J.A. Kellum, N.A. Pugh, L.A. Weissfeld, and J. Struck et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 2009 823 831
129. W.C. Albrich, F. Dusemund, K. Rüegger, M. Christ-Crain, W. Zimmerli, and T. Bregenzer et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm BMC Infect Dis 11 2011 1 12
130. S. Bello, A.B. Lasierra, E. Mincholé, S. Fandos, M.A. Ruiz, and E. Vera et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology Eur Respir J 39 2012 1144 1155
131. C. Prat, A. Lacoma, J. Domínguez, J. Papassotiriou, N.G. Morgenthaler, and F. Andreo et al. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia J Infect 55 2007 400 407
132. R. Seligman, J. Papassotiriou, N.G. Morgenthaler, M. Meisner, and P.J. Teixeira Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia Crit Care 12 2008 R11
133. R. Uusitalo-Seppälä, H. Peuravuori, P. Koskinen, T. Vahlberg, and E.M. Rintala Role of plasma bactericidal/permeability-increasing protein group IIA phospholipase A(2), C-reactive protein, and white blood cell count in the early detection of severe sepsis in the emergency department Scand J Infect Dis 44 2012 697 704
134. D.A. Del Portal, F. Shofer, M.E. Mikkelsen, P.J. Dorsey, D.F. Gaieski, and M. Goyal et al. Emergency department lactate is associated with mortality in older adults admitted with and without infections Acad Emerg Med 17 2010 260 268
135. J.P. Green, T. Berger, N. Garg, and N.I. Shapiro Serum lactate is a better predictor of short-term mortality when stratified by C-reactive protein in adult emergency department patients hospitalized for a suspected infection Ann Emerg Med 57 2011 291 295
136. O. Kruse, N. Grunnet, and C. Barfod Bloob lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review Scand J Trauma Resus Emerg Med 19 2011 74
137. N.I. Shapiro, M.D. Howell, D. Talmor, L.A. Nathanson, A. Lisbon, and R.E. Wolfe et al. Serum lactate as a predictor of mortality in emergency department patients with infection Ann Emerg Med 45 2005 524 528
138. M.E. Mikkelsen, A.N. Miltiades, D.F. Gaieski, M. Goyal, B.D. Fuchs, and C.V. Shah et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock Crit Care Med 37 2009 1670 1677
139. H.B. Nguyen, E.P. Rivers, B.P. Knoblich, G. Jacobsen, A. Muzzin, and J.A. Ressler et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock Crit Care Med 32 2004 1637 1642
140. S. Trzeiak, R.P. Dellinger, M.E. Chansky, R.C. Arnold, C. Schorr, and B. Milcarek et al. Serum lactate as a predictor of mortality in patients with infection Intensive Care Med 33 2007 970 977
141. M.D. Howell, M. Donnino, P. Clardy, D. Talmor, and N.I. Shapiro Occult hypoperfusion and mortality in patients with suspected infection Intensive Care Med 33 2007 1892 1899
142. N.I. Shapiro, C. Fisher, M. Donnino, L. Cataldo, A. Tang, and S. Trzeciak et al. The feasibility and accuracy of point-of-care lactate measurement in emergency department patients with suspected infection J Emerg Med 39 2010 89 94
143. P.A. Cardinal, E. Olano, C. Acosta, H. Bertullo, H. Albornoz, and H. Bagnulo Valor pronóstico del aclaramiento del lactato en las primeras 6 horas de evolución en medicina intensiva Med Intensiva 33 2009 166 170
144. E.J. Gallagher, K. Rodríguez, and M. Touger Agreement between peripheral venous and arterial lactate levels Ann Emerg Med 29 1997 479 483
145. J.G. Younger, J.L. Falk, and S.G. Rothrock Relationship between arterial and peripheral venous lactate levels Acad Emerg Med 3 1996 730 734
146. O.A. Gressner, A. Koch, E. Sanson, C. Trautwein, and F. Tacke High C5a levels are associated with increased mortality in sepsis patients no enhancing effect by actin-free Gc-globulin Clin Biochem 41 2008 974 980
147. H. Sungurtekin, U. Sungurtekin, and C. Balci Circulating complement (C3 and C4) for differentiation of SIRS from sepsis Adv Ther 23 2006 893 901
148. C.R. Flores La saturación de los servicios de urgencias: una llamada a la unidad Emergencias 23 2011 59 64
149. S. Krüger, S. Ewig, J. Kunde, O. Hartmann, R. Marre, and N. Suttorp et al. Assessment of inflammatory markers in patients with community-acquired pneumonia - Influence of antimicrobial pre-treatment. Results from the German competence network CAPNETZ Clinica Chimica Acta 411 2010 1929 1934
150. M. Meisner Procalcitonin. Experience with a new diagnostic tool for bacterial infection and systemic inflammation J Lab Med 23 1999 263 272
151. S. Knapp, S. Gibot, A. de Vos, H.H. Versteeg, M. Colonna, and T. van der Poll Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia J Immunol 173 2004 7131 7134
152. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
153. A. Julián-Jiménez, J. González-Castillo, and F.J. Candel González ¿Cuándo, dónde y cómo ingresar al paciente con neumonía adquirida en la comunidad? Rev Clin Esp 2012 10.1016/j.rce.2012.02.006
154. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G.Y. Perret Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis Crit Care Med 34 2006 1996 2003
155. J.M. Cisneros, J. Cobo, M. Pujol, J. Rodríguez, and M. Salavert Guía para el diagnóstico y tratamiento del paciente con bacteriemia Enferm Infecc Microbiol Clin 25 2007 111 130
156. P. Parra, J.J. Curbelo, A. Gullón, N. Ruiz-Giménez, C. Suárez, and C. Del Arco Mortalidad precoz en un hospital terciario: análisis de la calidad asistencial Emergencias 23 2011 430 436
157. S. Tomás, M. Chánovas, F. Roqueta, and T. Toranzo La seguridad del paciente en urgencias y emergencias: balance de cuatro años del Programa SEMES Seguridad Paciente Emergencias 24 2012 225 233
158. C.L. Fowler Procalcitonin for triage of patients with respiratory tract symptoms: a case study in the trial design process for approval of a new diagnostic test for lower respiratory tract infections Clin Infect Dis 52 2011 S351 S356
159. D.N. Gilbert Procalcitonin as a biomarker in respiratory tract infection Clin Infect Dis 52 2011 S346 S350
160. A. Lacoma, N. Rodríguez, C. Prat, J. Ruiz-Manzano, F. Andreo, and A. Ramírez et al. Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia Eur J Clin Microbiol Infect Dis 31 2012 825 833
161. S. Krüger, and T. Welte Biomarkers in community-acquired pneumonia Expert Rev Respir Med 6 2012 203 214
162. D.T. Huang, L.A. Weissfeld, J.A. Kellum, D.M. Yealy, L. Kong, and M. Martino et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia Ann Emerg Med 52 2008 48 58
163. F. Muller, M. Christ-Crain, T. Bregenzer, M. Krause, W. Zimmerli, and B. Mueller et al. Procalcitonin levels predict bacteremia in patients with community acquired pneumonia: a prospective cohort trial Chest 138 2010 121 129
164. M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, and M. Ieven et al. Guidelines for the management of adult lower respiratory tract infections Clin Microbiol Infect 17 Suppl 6 2011 1 24
165. R. Menéndez, A. Torres, J. Aspa, A. Capelastegui, C. Prat, and F. Rodríguez de Castro Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Archa Bronconeumol 46 2010 543 558
166. A. Julián-Jiménez, F.J. Candel, P. Piñera, J. González del Castillo, M.S. Moya, and M. Martínez Recomendaciones INFURG-SEMES: manejo de la infección respiratoria de vías bajas en urgencias Monografías de Emergencias 3 2009 1 21
167. G.W. Waterer, J. Rello, and R.G. Wunderink Management of community-acquired pneumonia in adults Am J Respir Crit Care Med 183 2011 157 164
168. G.M. Vail, Y.J. Xie, D.J. Haney, and C.J. Barnes Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae Infection 37 2009 358 364
169. A. Julián-Jiménez, M.J. Palomo de los Reyes, N. Laín-Terés, and J. Estebaran-Martín ¿Es posible mejorar la decisión de ingreso en el hospital en la neumonía adquirida en la comunidad? Rev Clin Esp 212 2012 52 53
170. A. Juan, J. Jacob, F. Llopis, C. Gómez-Vaquero, C. Ferré, and J.R. Pérez-Mas et al. Análisis de la seguridad y la eficacia de la unidad de corta estancia en el tratamiento de la neumonía adquirida en la comunidad Emergencias 23 2011 175 182
171. D. Aujesky, J.B. McCausland, J. Whittle, D. Scott, D.M. Yealy, and M.J. Fine Reasons why Emergency Departament providers do not rely on the Pneumonia Severity Index to determine the initial site of treatment for patients with pneumonia Clin Infect Dis 49 2009 e100 e108
172. R. Menéndez, R. Martínez, S. Reyes, J. Mensa, X. Filella, and M.A. Marcos et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 64 2009 587 591
173. W.C. Ziai, and J.J. Lewin III Update in the diagnosis and management of central nervous system infections Neurol Clin 26 2008 427 468
174. P. Ray, G. Baradou-Acossi, A. Viallon, D. Boutoille, M. Arthaud, and D. Trystam et al. Accuracy of cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis in case of negative gram-strained smear Am J Emerg Med 25 2007 179 184
175. A. Viallon, F. Zeni, C. Lambert, B. Pozzetto, B. Tardy, and C. Venet et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis Clin Infect Dis 28 1999 1313 1316
176. A. Julián-Jiménez, M. Flores, M.J. Palomo, and S. Brea Utilidad de la procalcitonina y la proteína C reactiva en las meningitis agudas en urgencias Neurología 2011 10.1016/j.nrl.2011.09.009
177. G.D. Mills, H.M. Lala, M.R. Oehley, A.B. Craig, K. Barrat, and D. Hood et al. Elevated procalcitonin as a diagnostic marker in meningococcal disease Eur J Clin Microbiol Infect Dis 25 2006 501 509
178. H. Honda, and D.K. Warren Central nervous system infections: meningitis and brain abscess Infect Dis Clin North Am 23 2009 609 623
179. M.G. Codina, M. de Cueto, D. Vicente, J.E. Echevarría, and G. Prats Diagnóstico microbiológico de las infecciones del sistema nervioso central Enferm Infecc Microbiol Clin 29 2011 127 134
180. C. Van Nieuwkoop, T.N. Bonten, J.W. Van't Wout, E.J. Kuijper, G.H. Groeneveld, and M.J. Becker et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study Critical Care 14 2010 R206
181. F.J. Candel, F. Martínez-Sagasti, M. Borges, M. Maseda, M. Herrera-Gutiérrez, and J. Garnacho-Montero et al. La depuración de endotoxina como tratamiento coadyuvante en la sepsis grave por microrganismos gramnegativos Rev Esp Quimioter 23 2010 115 121